technetium-tc-99m-sulfur-colloid and Weight-Loss

technetium-tc-99m-sulfur-colloid has been researched along with Weight-Loss* in 2 studies

Other Studies

2 other study(ies) available for technetium-tc-99m-sulfur-colloid and Weight-Loss

ArticleYear
In-111 labeled octreotide imaging of a primary carcinoid lesion undetected by conventional imaging studies in a patient with "chronic pancreatitis".
    Clinical nuclear medicine, 1996, Volume: 21, Issue:8

    This is a case report of a patient with an initial diagnosis of chronic pancreatitis who actually had metastatic carcinoid tumor. His symptoms of abdominal pain, weight loss, and diarrhea were manifestations of the large tumor bulk within the liver as well as carcinoid syndrome. Although abdominal CT scans showed multiple liver lesions, the primary lesion was not identified by conventional imaging studies. However, the mid-gut primary lesion was visualized on in-111 labeled octreotide scintigraphy; where the liver lesions were better delineated and seen to be separate from the normal pancreas when the Tc-99m sulfur colloid images were compared to the octreotide images.

    Topics: Abdominal Pain; Adult; Antineoplastic Agents, Hormonal; Carcinoid Tumor; Chronic Disease; Diagnosis, Differential; Diarrhea; Humans; Indium Radioisotopes; Intestinal Neoplasms; Liver Neoplasms; Male; Malignant Carcinoid Syndrome; Octreotide; Pancreatitis; Radionuclide Imaging; Technetium Tc 99m Sulfur Colloid; Weight Loss

1996
Effect of the Garren-Edwards gastric bubble on gastric emptying.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1989, Volume: 30, Issue:5

    The Garren-Edwards Gastric Bubble (GEGB) was introduced in 1984 as an alternative to surgery (jaw wiring, gastrointestinal bypass, vertical banded gastroplasty) for the treatment of morbid obesity in patients who had failed behavior modification therapy or dietary management for weight reduction. Its mechanism of action is unclear and previous reports have not demonstrated any significant consistent alteration in gastric emptying (GE) as measured by radionuclide techniques. Other proposed mechanisms include: placebo, hormonal, mechanical "satiety", behavioral modification, and neuronal. In order to determine the effect of the GEGB on GE, ten obese (mean % overweight = 89%) patients, 27-50 yr old (mean = 36 yr), had solid GE scans before and 5 wk after endoscopic placement of the bubble. GE scans were performed in six patients after removal (12 = wk residence time). The meal consisted of 300 microCi [99mTc]sulfur colloid in the form of a 300 kcal egg sandwich (egg white 248 g, white bread 40 g, butter 6 g; composition = CHO 40:PR 40: FAT 20) with 180 ml deionized water. Images were obtained in the anterior and posterior projections at 15-min intervals for 1 hr (four patients) or 2 hr (six patients) and the %GE (decay corrected geometric mean) was calculated. Unlike other studies involving the GEGB, adjunctive therapy in the form of dieting and behavior modification were not employed in this study. The effect of the GEGB alone in the treatment of obesity has not been previously evaluated. There was a significant (p less than 0.025) delay in gastric emptying at 1 hr (pre-bubble mean % gastric retention = 46%; bubble mean = 57%; n = 10). After removal, GE returned toward baseline (mean % gastric retention = 51%; n = 6) (p less than 0.05) (Student's t-test). The average weight loss was 5.5 lb (n = 10; p less than 0.025). One mechanism of action of the GEGB may be delayed gastric emptying resulting in early satiety and decreased food intake with resultant weight loss.

    Topics: Adult; Evaluation Studies as Topic; Female; Gastric Emptying; Humans; Middle Aged; Obesity, Morbid; Prostheses and Implants; Radionuclide Imaging; Stomach; Technetium Tc 99m Sulfur Colloid; Weight Loss

1989